These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15943854)

  • 21. Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
    Brzozowski T; Konturek PC; Mierzwa M; Drozdowicz D; Bielanski W; Kwiecien S; Konturek SJ; Stachura J; Pawlik WW; Hahn EG
    Helicobacter; 2006 Feb; 11(1):10-20. PubMed ID: 16423085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat shock protein 70 (HSP70) in gastric adaptation to aspirin in Helicobacter pylori infection.
    Konturek JW; Fischer H; Konturek PC; Huber V; Boknik P; Luess H; Neumann J; Brzozowski T; Schmitz W; Hahn EG; Domschke W; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):153-64. PubMed ID: 11321509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between interleukin-1beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori.
    Wang M; Furuta T; Takashima M; Futami H; Shirai N; Hanai H; Kaneko E
    J Gastroenterol; 1999; 34 Suppl 11():10-7. PubMed ID: 10616759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
    Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Di Mario F; Malfertheiner P
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1225-33. PubMed ID: 16611284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of H. pylori infection and eradication on p53, c-erbB-2 and Ki-67 in gastric mucosa.
    Brajsa K; Ferencic Z; Katicic M; Radosevic S; Presecki V; Spaventi R; Dominis M
    Hepatogastroenterology; 2006; 53(72):968-72. PubMed ID: 17153465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Helicobacter pylori eradication restores sonic hedgehog expression in the gastric mucosa of Mongolian gerbils.
    Nishizawa T; Suzuki H; Nakagawa I; Minegishi Y; Masaoka T; Iwasaki E; Hibi T
    Digestion; 2009; 79(2):99-108. PubMed ID: 19295210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood.
    Wex T; Kuester D; Vieth M; Treiber G; Krieg A; Roessner A; Malfertheiner P
    Scand J Gastroenterol; 2008; 43(10):1194-201. PubMed ID: 18609127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S; Hiratsuka T; Suzuki K; Kusunoki M; Wada K; Miyake K; Ohashi K; Shimizu M; Takahashi H; Gudis K; Kato S; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
    Kubben FJ; Sier CF; Schram MT; Witte AM; Veenendaal RA; van Duijn W; Verheijen JH; Hanemaaijer R; Lamers CB; Verspaget HW
    Helicobacter; 2007 Oct; 12(5):498-504. PubMed ID: 17760717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer.
    Fukuchi T; Ashida K; Yamashita H; Kiyota N; Tsukamoto R; Takahashi H; Ito D; Nagamatsu R
    J Gastroenterol; 2005 Apr; 40(4):350-60. PubMed ID: 15870971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-1beta and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes.
    Chang YW; Oh HC; Jang JY; Hwangbo Y; Lee JW; Lee HJ; Joo KR; Dong SH; Kim SS; Kim HJ; Kim BH; Chang R
    Scand J Gastroenterol; 2008; 43(10):1184-93. PubMed ID: 18609140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of somatostatin receptor subtype 3 in the gastric mucosa of dyspeptic patients in relation to Helicobacter pylori infection and a family history of gastric cancer.
    Stec-Michalska K; Peczek L; Krakowiak A; Michalski B; Chojnacki J; Knopik-Dabrowicz A; Klupinska G; Nawrot B
    J Gastroenterol Hepatol; 2008 Mar; 23(3):424-9. PubMed ID: 17683502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum pepsinogen I levels and acid secretion in Helicobacter pylori associated enlarged fold gastritis.
    Yasunaga Y; Shinomura Y; Kanayama S; Miyazaki Y; Bonilla Palacios JJ; Matsuzawa Y
    Ital J Gastroenterol; 1996; 28(8):457-61. PubMed ID: 9032589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of Helicobacter pylori infection on expression of macrophage migration inhibitory factor by T cells and macrophages in gastric mucosa.
    He XX; Yang J; Zheng XL; Ding YW; Shen QY; Liu W; Zhao YH
    Chin Med J (Engl); 2005 Jul; 118(14):1201-5. PubMed ID: 16117866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori eradication treatment modulates epithelial cell proliferation and tissue content of hepatocyte growth factor in the gastric mucosa.
    Suzuki M; Suzuki H; Masaoka T; Tanaka S; Suzuki K; Ishii H
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():158-64. PubMed ID: 15298622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persisting chronic gastritis and elevated Helicobacter pylori antibodies after successful eradication therapy.
    Veijola L; Oksanen A; Linnala A; Sipponen P; Rautelin H
    Helicobacter; 2007 Dec; 12(6):605-8. PubMed ID: 18001400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Time course changes in morphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers].
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME
    Ter Arkh; 2006; 78(2):26-31. PubMed ID: 16613092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.